发明名称 Isolated antibodies which bind to CXC chemokine receptor 4
摘要 The present invention provides antibodies which bind to CXC chemokine receptor 4 (CXCR4) and which do not induce significant apoptosis of CXCR4 expressing cells. Also provided are inter alia immunoconjugates and compositions comprising such antibodies and methods and uses involving such antibodies, particularly in the medical and diagnostic fields.
申请公布号 US8748107(B2) 申请公布日期 2014.06.10
申请号 US201113024698 申请日期 2011.02.10
申请人 Affitech Research AS 发明人 Kavlie Anita;Kiprijanov Sergej Michailovic
分类号 G01N33/53;C07K16/00;C12P21/08 主分类号 G01N33/53
代理机构 代理人
主权项 1. An isolated antibody which binds to CXC chemokine receptor 4 (CXCR4) and which does not induce significant apoptosis of CXCR4 expressing cells, wherein by the term not inducing significant apoptosis of CXCR4 expressing cells is meant that levels of apoptosis induced in the presence of an antibody are comparable to or not significantly different from levels of apoptosis induced in the absence of an antibody, and wherein said antibody comprises at least one heavy chain variable region that comprises three CDRs and at least one light chain variable region that comprises three CDRs, wherein said heavy chain variable region comprises: (i) a variable heavy (VH) CDR1 that has the amino acid sequence of S/G Y X3 M/I H/S (SEQ ID NO: 126), or X1 Y X3 M H (SEQ ID NO: 127) or S Y X3 M H (SEQ ID NO: 128); wherein X1 can be S or G, preferably S; X3 can be G or W or Y or A, preferably W; (ii) a VH CDR2 that has the amino acid sequence of X1 I X3 X4 D G S X8 X9 X10 Y A D S V K G (SEQ ID NO:129); wherein X1 can be V or R, preferably R; X3 can be S or N, preferably N; X4 can be Y or S, preferably S; X8 can be N or S, preferably S; X9 can be K or T, preferably T; and X10 can be Y or S, preferably S; or a VH CDR2 that has the amino acid sequence of X1 I X3 P X5 X6 G X8 X9 N Y A Q K F Q G (SEQ ID NO: 131); wherein X1, can be R or G, preferably R; X3 can be N or I, preferably N; X5 can be N or I, preferably N; X6 can be S or F, preferably S; X8 can be G or T, preferably G; and X9 can be T or A, preferably T; and (iii) a VH CDR3 that has the amino acid sequence of SEQ ID NO:s 3, 9, 15 or 21.
地址 Oslo NO